Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 97 points (0.5%) at 17,727 as of Wednesday, July 29, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,089 issues advancing vs. 896 declining with 165 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.5%. Top gainers within the industry include

NuVasive

(

NUVA

), up 8.2%,

Quintiles Transnational Holdings

(

Q

), up 3.9%,

Waters

(

WAT

), up 2.3% and

Quest Diagnostics

(

DGX

), up 1.6%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

HCA Holdings

(

HCA

) is one of the companies pushing the Health Services industry higher today. As of noon trading, HCA Holdings is up $1.33 (1.4%) to $93.62 on light volume. Thus far, 991,369 shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.5 million shares. The stock has ranged in price between $92.13-$94.16 after having opened the day at $92.50 as compared to the previous trading day's close of $92.29.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $38.1 billion and is part of the health care sector. Shares are up 25.8% year-to-date as of the close of trading on Tuesday. Currently there are 18 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates

HCA Holdings

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

HCA Holdings Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Baxter International

(

BAX

) is up $0.40 (1.1%) to $38.50 on light volume. Thus far, 4.1 million shares of Baxter International exchanged hands as compared to its average daily volume of 11.1 million shares. The stock has ranged in price between $38.05-$38.76 after having opened the day at $38.18 as compared to the previous trading day's close of $38.09.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $20.5 billion and is part of the health care sector. Shares are up 3.9% year-to-date as of the close of trading on Tuesday. Currently there are 2 analysts who rate Baxter International a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates

Baxter International

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, notable return on equity, attractive valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full

Baxter International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

CVS Health

(

CVS

) is up $1.53 (1.4%) to $113.17 on average volume. Thus far, 2.0 million shares of CVS Health exchanged hands as compared to its average daily volume of 4.0 million shares. The stock has ranged in price between $111.65-$113.63 after having opened the day at $111.67 as compared to the previous trading day's close of $111.64.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. CVS Health has a market cap of $123.9 billion and is part of the health care sector. Shares are up 15.9% year-to-date as of the close of trading on Tuesday. Currently there are 17 analysts who rate CVS Health a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates

CVS Health

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

CVS Health Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).